MUC16 and ovarian carcinoma: Abrego et al., using data from the UK Collaborative Trial of Ovarian Cancer Screening, also tested different combinations of biomarkers, including CA125, for the prediction of OC using recurrent neural networks (RNNs) with longitudinal observations.